65,437 trials
Lung Cancer
Primary: Lung Cancer Screening Uptake — 1; 5 Participants
Healthy
Primary: Oxygen Saturation Performance of Philips FAST SpO₂ With Masimo Pulse Oximeter Sensor (RD SET® Adt) — 1.84 % of oxygen saturated hemoglobin
Breast Cancer
Primary: Total Practice Time as Assessed in Minutes Within the Study Application. — 0.2; 0.2 Minutes
PTSD
Primary: Change in Post Traumatic Stress Disorder Symptom Severity - Clinician Rated — -10.1; -12 units on a scale
Healthy
Primary: Maximum Observed Plasma Concentration (Cmax) of Manogepix in Part-1 — 5750; 10865; 8343; 13874 ng/mL
Larynx Cancer · Laryngectomy; Status
Primary: High Speed Video Endoscopy Recordings — 53; 2; 2; 38 Participants
Friedreich Ataxia 1
Primary: Within-Participant Change in Peak V02 (Maximal Oxygen Uptake on Cardiopulmonary Exercise Testing) — 0.06; -0.06; 0.1; 0.03 L/min
Post-Surgical Hypoparathyroidism
Primary: Percent Change in Fractional Excretion of Calcium (FECa) — -39 percentage of change
Febrile Illness
Primary: Validate the Clinical Accuracy of the Timmy3 Thermometer Algorithm for Age Group >=5 Years - Clinical Bias — -0.08; -0.21 degree Celsius
Adult Grade III Lymphomatoid Granulomatosis · B-cell Chronic Lymphocytic Leukemia · Contiguous Stage II Adult Diffuse Large Cell Lymphoma
Primary: Dose-limiting Toxicity (Phase I) — 0; 0; 2 Participants
Pain, Procedural · Pain, Postoperative · Coronary Artery Bypass Surgery
Primary: Mediastinal Chest Tube Pain — 1.38; 1.76; 1.43; 0.21 score on a scale
Glucose Metabolism Disorders
Primary: Change in Muscle Insulin Sensitivity — 19.0; 13.5 (nmol/kg FFM/min) / (µU/mL) — p=0.05
HIV/AIDS
Primary: Biomedical HIV Prevention Uptake at 4 Weeks — 23.7; 24.1 % of participants
Pain
Primary: Minimally Important Clinical Change in Worst Pain Intensity — 4; 2; 16; 14 Participants
Anxiety
Primary: Number of Participants Who Completed Patient-Reported Outcomes (PROs) Questionnaires — 61; 61; 61; 61 Participants